VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 143 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $117,000 | -94.1% | 11,830 | -84.5% | 0.01% | -98.7% |
| Q4 2018 | $1,991,000 | +680.8% | 76,204 | +318.2% | 0.56% | +704.3% |
| Q1 2017 | $255,000 | -1.9% | 18,223 | +11.8% | 0.07% | -6.8% |
| Q4 2016 | $260,000 | -11.3% | 16,296 | -39.0% | 0.07% | -11.9% |
| Q3 2013 | $293,000 | -78.2% | 26,733 | -84.0% | 0.08% | -79.8% |
| Q2 2013 | $1,346,000 | – | 166,634 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |